201 related articles for article (PubMed ID: 20364003)
1. Synchronization of cortisol circadian rhythm by the pineal hormone melatonin in untreatable metastatic solid tumor patients and its possible prognostic significance on tumor progression.
Brivio F; Fumagalli L; Fumagalli G; Pescia S; Brivio R; Di Fede G; Rovelli F; Lissoni P
In Vivo; 2010; 24(2):239-41. PubMed ID: 20364003
[TBL] [Abstract][Full Text] [Related]
2. Total pineal endocrine substitution therapy (TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic solid tumor patients: a phase II study.
Lissoni P; Malugani F; Brivio F; Piazza A; Vintimilla C; Giani L; Tancini G
Neuro Endocrinol Lett; 2003; 24(3-4):259-62. PubMed ID: 14523367
[TBL] [Abstract][Full Text] [Related]
3. A study of light/dark rhythm of melatonin in relation to cortisol and prolactin secretion in schizophrenia.
ViganĂ² D; Lissoni P; Rovelli F; Roselli MG; Malugani F; Gavazzeni C; Conti A; Maestroni G
Neuro Endocrinol Lett; 2001 Apr; 22(2):137-41. PubMed ID: 11335890
[TBL] [Abstract][Full Text] [Related]
4. Anticancer neuroimmunomodulation by pineal hormones other than melatonin: preliminary phase II study of the pineal indole 5-methoxytryptophol in association with low-dose IL-2 and melatonin.
Lissoni P; Fumagalli L; Paolorossi F; Rovelli F; Roselli MG; Maestroni GJ
J Biol Regul Homeost Agents; 1997; 11(3):119-22. PubMed ID: 9498162
[TBL] [Abstract][Full Text] [Related]
5. Oncostatic activity of pineal neuroendocrine treatment with the pineal indoles melatonin and 5-methoxytryptamine in untreatable metastatic cancer patients progressing on melatonin alone.
Lissoni P; Rovelli F; Frassineti A; Fumagalli L; Malysheva O; Conti A; Maestroni G
Neuro Endocrinol Lett; 2000; 21(4):319-323. PubMed ID: 11455367
[TBL] [Abstract][Full Text] [Related]
6. Neuroimmunomodulation in medical oncology: application of psychoneuroimmunology with subcutaneous low-dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumors.
Lissoni P; Brivio F; Fumagalli L; Messina G; Vigoré L; Parolini D; Colciago M; Rovelli F
Anticancer Res; 2008; 28(2B):1377-81. PubMed ID: 18505083
[TBL] [Abstract][Full Text] [Related]
7. Role of the pineal gland in the control of macrophage functions and its possible implication in cancer: a study of interactions between tumor necrosis factor-alpha and the pineal hormone melatonin.
Lissoni P; Barni S; Tancini G; Brivio F; Tisi E; Zubelewicz B; Braczkowski R
J Biol Regul Homeost Agents; 1994; 8(4):126-9. PubMed ID: 7660855
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies.
Lissoni P; Bolis S; Brivio F; Fumagalli L
Anticancer Res; 2000; 20(3B):2103-5. PubMed ID: 10928160
[TBL] [Abstract][Full Text] [Related]
9. Alteration of hypothalamus-pituitary-adrenal glands axis in colorectal cancer patients.
Mussi C; Angelini C; Crippa S; Caprotti R; Fumagalli L; Motta V; Uggeri F
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxxviii-ccxxxi. PubMed ID: 15244187
[TBL] [Abstract][Full Text] [Related]
10. Is there a role for melatonin in supportive care?
Lissoni P
Support Care Cancer; 2002 Mar; 10(2):110-6. PubMed ID: 11862501
[TBL] [Abstract][Full Text] [Related]
11. Immune and endocrine mechanisms of advanced cancer-related hypercortisolemia.
Lissoni P; Brivio F; Fumagalli L; Messina G; Secreto G; Romelli B; Fumagalli G; Rovelli F; Colciago M; Brera G
In Vivo; 2007; 21(4):647-50. PubMed ID: 17708360
[TBL] [Abstract][Full Text] [Related]
12. Determination of whole body circadian phase in lung cancer patients: melatonin vs. cortisol.
Mazzoccoli G; Giuliani F; Sothern RB
Cancer Epidemiol; 2012 Feb; 36(1):e46-53. PubMed ID: 22000330
[TBL] [Abstract][Full Text] [Related]
13. Neuroimmunotherapy of untreatable metastatic solid tumors with subcutaneous low-dose interleukin-2, melatonin and naltrexone: modulation of interleukin-2-induced antitumor immunity by blocking the opioid system.
Lissoni P; Malugani F; Malysheva O; Kozlov V; Laudon M; Conti A; Maestroni G
Neuro Endocrinol Lett; 2002 Aug; 23(4):341-4. PubMed ID: 12195238
[TBL] [Abstract][Full Text] [Related]
14. Preliminary study on modulation of the biological effects of tumor necrosis factor-alpha in advanced cancer patients by the pineal hormone melatonin.
Brackowski R; Zubelewicz B; Romanowski W; Lissoni P; Barni S; Tancini G; Maestroni GJ
J Biol Regul Homeost Agents; 1994; 8(3):77-80. PubMed ID: 7754792
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic activity of melatonin in advanced cancer patients.
Lissoni P; Rovelli F; Malugani F; Bucovec R; Conti A; Maestroni GJ
Neuro Endocrinol Lett; 2001; 22(1):45-7. PubMed ID: 11335879
[TBL] [Abstract][Full Text] [Related]
16. Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms.
Lissoni P
Pathol Biol (Paris); 2007; 55(3-4):201-4. PubMed ID: 17446010
[TBL] [Abstract][Full Text] [Related]
17. Circadian rhythms: glucocorticoids and arthritis.
Cutolo M; Sulli A; Pizzorni C; Secchi ME; Soldano S; Seriolo B; Straub RH; Otsa K; Maestroni GJ
Ann N Y Acad Sci; 2006 Jun; 1069():289-99. PubMed ID: 16855156
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory properties of a pineal indole hormone other than melatonin, the 5-methoxytryptophol.
Lissoni P; Pittalis S; Rovelli F; Zecchini S; Casati M; Tremolada M; Pelizzoni F
J Biol Regul Homeost Agents; 1996; 10(1):27-30. PubMed ID: 9049779
[TBL] [Abstract][Full Text] [Related]
19. Melatonin and cortisol circadian secretion during ethanol withdrawal in chronic alcoholics.
Fonzi S; Solinas GP; Costelli P; Parodi C; Murialdo G; Bo P; Albergati A; Montalbetti L; Savoldi F; Polleri A
Chronobiologia; 1994; 21(1-2):109-12. PubMed ID: 7924629
[TBL] [Abstract][Full Text] [Related]
20. [Prostaglandin-E2 (PGE2) and interleukin-1 (IL-1) production from plastic-adherent peripheral blood mononuclear cells, and serum and urinary glucocorticoid levels in cancer patients treated with systemic chemotherapy--with special reference to circadian rhythm of serum cortisol levels in cancer].
Ito K; Asai R; Nakao I; Ohashi Y; Kataoka T; Saito T
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):489-93. PubMed ID: 2321978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]